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The eﬀ ect of mobile phone text-message reminders on 
Kenyan health workers’ adherence to malaria treatment 
guidelines: a cluster randomised trial
Dejan Zurovac, Raymond K Sudoi, Willis S Akhwale, Moses Ndiritu, Davidson H Hamer, Alexander K Rowe, Robert W Snow
Summary
Background Health workers’ malaria case-management practices often diﬀ er from national guidelines. We assessed 
whether text-message reminders sent to health workers’ mobile phones could improve and maintain their adherence 
to treatment guidelines for outpatient paediatric malaria in Kenya.
Methods From March 6, 2009, to May 31, 2010, we did a cluster-randomised controlled trial at 107 rural health 
facilities in 11 districts in coastal and western Kenya. With a computer-generated sequence, health facilities were 
randomly allocated to either the intervention group, in which all health workers received text messages on their 
personal mobile phones on malaria case-management for 6 months, or the control group, in which health workers 
did not receive any text messages. Health workers were not masked to the intervention, although patients were 
unaware of whether they were in an intervention or control facility. The primary outcome was correct management 
with artemether-lumefantrine, deﬁ ned as a dichotomous composite indicator of treatment, dispensing, and 
counselling tasks concordant with Kenyan national guidelines. The primary analysis was by intention to treat. The 
trial is registered with Current Controlled Trials, ISRCTN72328636.
Findings 119 health workers received the intervention. Case-management practices were assessed for 2269 children 
who needed treatment (1157 in the intervention group and 1112 in the control group). Intention-to-treat analysis 
showed that correct artemether-lumefantrine management improved by 23·7 percentage-points (95% CI 7·6–40·0; 
p=0·004) immediately after intervention and by 24·5 percentage-points (8·1–41·0; p=0·003) 6 months later.  
Interpretation In resource-limited settings, malaria control programmes should consider use of text messaging to 
improve health workers’ case-management practices. 
Funding The Wellcome Trust.
Introduction
With more than 5 billion mobile phone users worldwide, 
text-messaging technology has changed the face of com-
munication globally, and is increasingly used to pro mote 
health and to prevent disease.1,2 The application of text 
messaging for behavioural change in health is at an early 
stage of research. Randomised controlled trials of such use 
of text messaging are scarce, with only two trials from low-
resource settings.3,4 Most randomised controlled trials from 
high-income countries have focused on remin ders to 
improve patients’ adherence to treatment, and all studies 
assessed only short-term eﬀ ects of the inter vention.5–7 We 
know of no other study that has assessed the use of text 
messaging to target the behaviour of health workers.5–7
In Africa, adherence by health workers to malaria case-
management guidelines for artemisinin-based combination 
treatment is vital to maximise patients’ adherence to treat-
ment,8,9 and, therefore, treatment success.10 Despite simple 
guidelines for the management of febrile children, non-
adherent prescription, dosing, and dispensing of drugs, 
and counselling practices that do not conform to these 
established guidelines have been widely reported at out-
patient facilities across the continent.11–14 Complex inter ven-
tions such as high quality in-service training, supervision, 
audit with feedback, and quality improvement schemes 
have been suggested as interventions to improve the use of 
drugs and adherence to guidelines in low-resource set-
tings.15,16 However, little information exists about the cost-
eﬀ ectiveness of such interventions and about the possible 
existence of simple, inexpensive, and eﬀ ective interven-
tions that could be easily replicated in similar settings.16
Notwithstanding poor health indicators, restricted 
resources, poor infrastructure, and weak health systems, 
many African countries have overcome communication 
problems with the widespread use of mobile phone 
technology.2,17 In this study, we report a randomised 
controlled trial in Kenya designed to test whether text-
message reminders sent to health workers’ mobile 
phones could improve and maintain health-workers’ 
adherence to national guidelines for the management of 
outpatient paediatric malaria with the recommended 
artemisinin-based combination treatment in Kenya—
artemether-lumefantrine.
Methods
Study population
This cluster randomised controlled trial was done at all 
107 rural government health facilities (dispensaries and 
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health centres) in 11 districts in two malaria endemic areas 
in Kenya: Greater Kwale, located along the Indian Ocean 
coast with a population of 650 000 people; and Greater 
Kisii and Gucha, located in the western highlands with a 
population of 1 030 000 people. In both areas, artemether-
lumefantrine was deployed to health facilities in 
August, 2006. Between September, 2006, and July, 2009, 
the main artemether-lumefantrine implementation 
activities in study districts consisted of three rounds of 
malaria case-management training sessions for health 
workers and dissemination of national guideline 
documents and drug management wall charts.
Written informed consent was obtained from all 
interviewed carers and health workers. The study protocol 
was approved by the University of Oxford (OXTREC 
No 3808) and Kenya Medical Research Institute (SSC 
No 1329). The trial is registered with Current Controlled 
Trials, ISRCTN72328636.
Randomisation and masking
All health facilities (study clusters), stratiﬁ ed by study 
area, were randomly allocated to either the intervention 
or control group, with a computer-generated sequence 
(generated by the research team). Researchers and health 
workers were not masked to intervention although 
patients and carers were unaware whether they were in 
an intervention or control group. 
Procedures
The intervention was a one-way communication of text-
message reminders about paediatric malaria case-
management sent to health workers’ personal mobile 
phones. All health workers doing outpatient consultations 
in the intervention group received text messages about 
malaria case-management for 6 months. The intervention 
did not include the provision of a mobile phone. The key 
messages addressed recommendations from the Kenyan 
national malaria guidelines18 and training manuals.19 The 
messages were in English, the language of pre-service 
and in-service training of Kenyan health workers.19 We 
created ten diﬀ erent text-messages (panel 1) to com-
municate the content and order of the key aspects of the 
outpatient clinical process with respect to paediatric 
malaria case management. For 5 working days (Monday 
to Friday), two text messages (one at 9 am and one at 
2 pm) were sent daily (excluding public holidays) to every 
health worker’s mobile phone. The same process was 
repeated every week for 6 months. This long intervention 
period was selected to ensure high exposure to the 
intervention to show proof of concept. Each case-
manage ment message was up to 120 characters long. To 
increase the probability that health workers would read 
the messages, each message was complemented with a 
quote that was up to 40 characters long and unrelated to 
malaria case-management but designed to be motivating, 
entertaining, or merely attention-getting.20 The quotes 
were unique to each message sent to health workers. 
The maximum number of characters in each message 
was 160, which is the maximum amount of text that can 
be sent in a text message to most mobile phones in 
Kenya. Before the trial, the text messages were pretested 
in neighbouring study districts during two rounds of 
individual interviews with 20 health workers who had 
Panel 1: Verbatim content and schedule of text-messages 
(ten examples)
Message one (Monday morning): 
Check ALL sick children <5yrs for any severe signs! Also check 
for fever, cough, diarrhea, pallor & any other problem. 
Quote:“Persistent work triumphs” 
Message two (Monday afternoon): 
Child has FEVER when complained by mother or child is hot 
or Temp is >=37·5 - Pls ask mother, touch child & take Temp! 
Quote:”Actions speak louder than words” 
Message three (Tuesday morning): 
TREAT with AL all children under 5yrs weighing >=5kg 
coming with FEVER for ﬁ rst visit & without severe signs. 
Quote:”Opportunity seldom knocks twice” 
Message four (Tuesday afternoon): 
For ﬁ rst visit of child <5yrs malaria test IS NOT NEEDED - 
Treat fever with AL & treat any other present illness! 
Quote:“Better be safe than sorry” 
Message ﬁ ve (Wednesday morning): 
Prescribe AL based on WEIGHT: 6 tab for 5-14kg;12 tab for 
15-24 kg;18 tab for 25-34kg;24 tab for >=35kg. 
Quote:”A goal without a plan is just a wish” 
Message six (Wednesday afternoon):
If WEIGHT suitable AL pack is out of stock, IMPROVISE with 
available AL - don’t give other antimalarial if you have AL! 
Quote:”Little by little one walks far” 
Message seven (Thursday morning): 
Give FIRST AL DOSE under observation at facility even if no 
food is available - if vomited within 30min REPEAT dose. 
Quote:”Two wrongs do not make a right” 
Message eight (Thursday afternoon): 
Advise mother to give SECOND DOSE of AL after 8hrs, then 
to give dose every 12hrs until all doses are ﬁ nished. 
Quote:”Failing to plan is planning to fail” 
Message nine (Friday morning): 
Advise mother to FINISH all AL doses over 3 days even if the 
child feels better after few doses! 
Quote:”A smile you sent, will always return” 
Message ten (Friday afternoon): 
Advise mother to give AL AFTER FEEDING child & if VOMITED 
within 30min to REPEAT dose & return for replacement dose. 
Quote:”The greatest wealth is health” 
AL= artemether-lumefantrine. Pls=please. Tab=tablet. Temp=temperature.
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similar roles to health workers in the study areas. 
This pretesting showed that most messages were 
understood—some messages needed further simpli-
ﬁ cation and reﬁ nement before being ﬁ nalised and 
eventually used.
We programmed the computerised text-message 
distribution system on a desktop server interfaced with 
the network of a local cellular-service provider through a 
global system for mobile communication modem. The 
system ensured automated delivery of text-message 
content at predeﬁ ned transmission times to a list of 
mobile phone numbers. The performance of the 
distribution system was tested in two rounds: ﬁ rst on 
40 mobile phone numbers during 6 weeks from 
Oct 01, 2008, to Nov 11, 2008, and then on 120 recipients 
from Feb 02, 2009, to Feb 06, 2009.
To assess the intervention, we did three health facility 
surveys: one before the intervention began (March 6, 2009, 
to April 3, 2009) to establish a baseline; one at 6 months, 
just after the end of the intervention (Nov 12, 2009, to 
Dec 10, 2009), to assess immediate post-intervention 
eﬀ ects; and one 6 months after the intervention (May 5, 
2010, to May 31, 2010) to assess retained eﬀ ects.
During the baseline survey, we explained the purpose of 
the text-message intervention and health-facility surveys 
to all health workers in the intervention and control 
facilities who did consultations for sick children on the 
day of the survey. On completion of the baseline survey, 
study nurses visited all 120 outpatient health workers at 
intervention facilities and invited them to participate in 
the study. One health worker did not have a mobile phone 
and was excluded from the study. The remaining 
119 health workers agreed to participate and provided 
written informed consent. All health workers in 
intervention facilities were told that messages would 
include quotes unrelated to malaria; therefore the 
possibility of quotes having a distracting or confusing 
eﬀ ect was presumably minimised. Intervention delivery 
ran from May 4, 2009, to Oct 30, 2009. 33 361 text messages 
were sent to 119 health workers on 150 phone numbers 
(31 health workers had more than one number). For those 
health workers who had more than one phone number 
(usually two), the intervention was sent to both numbers 
to increase likelihood that the message would be delivered 
to the health worker, irrespective of the number they used 
at the time of delivery. 
During each survey, health facilities were visited for 
1 day and all sick children younger than 5 years who 
presented to outpatient departments underwent rapid 
screening by study nurses when they were ready to leave 
the facility. Screening consisted of the collection of the 
following information: age, weight, temperature, history 
of fever, absence of routine negative malaria test, signs of 
severe disease, and whether the visit was for an initial or 
follow-up consultation. For children meeting the criteria 
for artemether-lumefantrine management (panel 2), 
study nurses did a structured interview with carers, 
during which information about previous use of 
antimalarial treatment, routine diagnostic results, drugs 
prescribed, and dispensing and counselling tasks done 
during the facility visit was recorded. At the end of the 
survey, all health workers who saw recruited children 
were interviewed. Basic information about health-worker 
demographics, access to guidelines, exposure to in-service 
Panel 2: National recommendations and deﬁ nition of the primary outcome
National recommendations for the management of uncomplicated malaria in 
children younger than 5 years
• In areas with high risk of malaria, any child with fever or history of fever and no severe 
signs should be presumptively classiﬁ ed and treated as malaria. The use of 
parasitological diagnosis is not a prerequisite for treatment.
• The recommended ﬁ rst-line treatment for uncomplicated malaria in children who 
weigh 5 kg or more is AL, in a weight-speciﬁ c six-dose regimen given over 3 days. 
• The second dose of AL should be taken after 8 h.
• AL should preferably be taken with a meal.
• The ﬁ rst dose of AL should be given at a health facility under the observation of the 
health worker even if the patient has not eaten.
• Carers should have the AL dosing schedule explained to them.
• If vomiting occurs within 30 min of taking the drug, the AL dose should be repeated.
• The health worker should emphasise that all six doses should be taken over 3 days, 
even if a patient feels better after a few doses.
Study deﬁ nition of children who needed AL according to the guidelines included 
children with all of the following attributes:
• Child presenting to a study health facility for an initial visit.
• Younger than 5 years old.
• Weight of 5 kg or more.
• Absence of general danger signs (inability to drink or breastfeed, history of 
convulsions, lethargy or unconsciousness, and vomiting), neck stiﬀ ness, and 
severe pallor.
• History of fever during present illness or a temperature of 37·5°C or more.
• Absence of previous use of AL during this illness.
• Absence of routine negative malaria test.
Primary outcome*—% of children needing AL who were correctly managed 
Correct AL management included children whose carer did task one to four:
1 Antimalarial prescribed—proxy for malaria diagnosis.
2 AL prescribed. 
3 AL prescribed in recommended weight-speciﬁ c dose.
4 AL prescribed tablets dispensed to patients to take home.
And at least four of the following six dispensing and counselling tasks:
5  First AL dose given at a health facility.
6 Carer advised on number of tablets per dose, number of doses per day, and number 
of days of treatment.
7 Carer advised to give second dose after 8 h.
8 Carer advised to give AL after a meal.
9 Carer advised what to do if a child vomits everything.†
10 Carer advised to give all doses even if child feels better.
AL=artemether-lumefantrine. *Prespeciﬁ ed primary protocol outcome which included all components from one to six was 
expanded because the intervention also included components seven to ten, no evidence exists that completion of dispensing and 
counselling components ﬁ ve to six results in better outcomes than completion of tasks seven to ten, and the expanded outcome 
based on ten criteria in combination with individual component outcomes in patient subsets was deemed more informative to 
assess all aspects of the intervention. †A child who cannot hold down food, ﬂ uids, or oral drugs.
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training, supervision, and intervention text messages 
received was recorded. Finally, each facility was assessed 
to ﬁ nd out the availability of drugs, malaria diagnostics, 
wall charts, and retrospective malaria morbidity in the 
previous 6 months. 
We used recommendations speciﬁ ed in national 
malaria guidelines and training materials for the 
management of uncomplicated malaria in children 
younger than 5 years to identify children who needed 
treatment and drug management tasks that should be 
done (panel 2). Kenyan guidelines valid at the time of 
the study recommend that in areas with high risk of 
malaria all children who weigh 5 kg or more with fever 
or a history of fever, and who present for an initial 
outpatient visit without signs of severe disease should 
be presumptively treated with artemether-lumefantrine. 
Because of some ambiguity in the guidelines for the use 
of malaria testing in this age group, which do not 
provide recommendation on how to treat test-negative 
children, children who were tested and had a negative 
result were excluded from the deﬁ nition. The primary 
outcome was a composite indicator for correct 
artemether-lumefantrine management; this consisted 
of completion of all four treatment tasks that were 
deemed mandatory for correct management of malaria 
and at least four of six dispensing and counselling tasks 
(panel 2). We also did exploratory analyses to assess 
quality of care with two additional composite deﬁ nitions: 
completion of all four treatment tasks and at least ﬁ ve of 
six dispensing and counselling tasks, and completion of 
all ten tasks. Finally, completion of each of ten individual 
tasks was assessed in subsets of children.
Statistical analysis
We calculated the sample size with unpublished data 
collected in study districts during health-facility surveys 
undertaken in 2006.21 We hypothesised that the 
intervention would improve correct artemether-
lumefantrine management by at least 25% (from an 
assumed 9% correctly managed children at baseline to 
at least 34% at both follow-up surveys). Therefore, 
assuming a level of conﬁ dence of 95%, power of 90%, 
baseline prevalence of 9%, an eﬀ ect size of 25%, 
intraclass correlation coeﬃ  cient of 0·79, and average 
cluster size of six children, the minimum number of 
clusters or facilities was 52, with 312 eligible children in 
each group of the trial. To account for the possibility of 
complete artemether-lumefantrine stock-out at a facility 
on a survey day, which would preclude assessment of 
drug management at such facilities, all 107 functional 
facilities in the study area were included.
Data were double-entered and veriﬁ ed with Microsoft 
Access 2007. Analyses were done at the patient level and 
were restricted to children seen at facilities where 
artemether-lumefantrine was in stock on survey days. 
Only one facility in the control group during the 
immediate post-intervention survey did not have the 
drug. First, we did an intention-to-treat-analysis. Second, 
we did a per-protocol analysis in which analyses during 
the follow-up surveys were restricted to children seen by 
health workers who were fully exposed to the intervention 
in intervention facilities or not exposed to the intervention 
in control facilities. 
The intervention eﬀ ect was assessed at two timepoints: 
immediately after the end of the intervention to assess 
short-term eﬀ ects on malaria case-management, and 
6 months after the end of the intervention to establish 
whether there was sustained improvement of the quality 
of care given to children with malaria. The eﬀ ect size 
of the intervention was measured with diﬀ erence-
of-diﬀ erences analysis—ie, (follow-up – baseline)intervention 
minus (follow-up – baseline)control.
We used STATA (version 11) for descriptive analyses 
and SAS (version 9.2) for analyses to estimate diﬀ erence-
of-diﬀ erences eﬀ ect sizes, corresponding 95% CIs and 
p values, and confounding. We used the SAS Genmod 
procedure with an identify link function and binomial 
distribution so that the parameter estimates of the model 
were risk diﬀ erences.22 The model contained variables 
for study group (intervention vs control), time one 
(baseline vs follow-up survey 1), time two (baseline vs 
follow-up survey two), a group-time-one interaction 
term, and a group-time-two interaction term. The model 
parameter estimates that correspond to the interaction 
terms are the diﬀ erence-of-diﬀ erences eﬀ ect sizes. The 
model used generalised estimating equations with an 
 Intervention group Control group
 Baseline Follow-up one Follow-up two Total Baseline Follow-up one Follow-up two Total
Enrolled (n) 549 482 436 1467 528 456 401 1385
Met artemether-lumefantrine 
management criteria and included in 
intention-to-treat analysis (n)
439 391 327 1157 422 358* 332 1112
Met artemether-lumefantrine 
management criteria and included in 
per-protocol analysis (n)
439 299 285 1023 422 354 320 1096
*Seven children from one facility met AL management criteria but were excluded from analysis because the facility had no artemether-lumefantrine.
Table 1: Number of children enrolled and analysed, by study group and survey time
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independent working correlation structure to account 
for the correlated nature of the data. We examined the 
eﬀ ects of 13 factors (eg, study area, preservice and in-
service training, supervision, wall charts, guidelines, and 
drug availability) on the main study eﬀ ects by entering 
factors into models one at a time. Any factor that changed 
either of the two diﬀ erence-of-diﬀ erences eﬀ ect sizes by 
more than 20% was regarded as a confounder and 
retained in the ﬁ nal model. Because no factor changed 
an eﬀ ect size by more than 16% in either the intention-
to-treat or per-protocol analyses, the ﬁ nal model 
contained no confounders. Statistical signiﬁ cance was 
deﬁ ned as p<0·05.
Role of the funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
Table 1 shows the number of children enrolled into the 
study at each survey, and the number of children included 
in intention-to-treat and per-protocol analyses. No carer 
of a sick child refused to participate in the study. 
Characteristics of health facilities and children needing 
Baseline  Follow-up one Follow-up two  
Control Intervention Control Intervention Control Intervention
Health facilities
Total number of facilities (n) 53 54 53 54 53 54
Health facilities in Greater Kwale area 26 (49%) 26 (48%) 26 (49%) 26 (48%) 26 (49%) 26 (48%)
Dispensary level 46 (87%) 46 (85%) 46 (87%) 46 (85%) 46 (87%) 46 (85%)
Malaria microscopy available 12 (23%) 17 (32%) 13 (25%) 16 (30%) 12 (23%) 17 (32%)
Any AL pack in stock 53 (100%) 54 (100%) 52 (98%) 54 (100%) 53 (100%) 54 (100%)
All weight-speciﬁ c AL packs in stock 33 (62%) 33 (61%) 9 (17%) 7 (13%) 5 (9%) 10 (19%)
At least one AL management wall chart exposed 33 (62%) 33 (61%) 39 (74%) 34 (63%) 43 (81%) 41 (76%)
Characteristics of children needing AL management
Total number of children (n) 422 439 358 391 332 327
Child level characteristics
Age (months) 23 (21–24) 22 (21–23) 24 (22–25) 24 (23–26) 25 (23–26) 23 (22–25)
Weight (kg) 10·2 (9·9–10·4) 10·1 (9·8–10·4) 10·3 (10–10·6) 10·5 (10·2–10·7) 10·6 (10·3–10·9) 10·3 (10–10·6)
Temperature (oC) 37·2 37·2 37·3 37·4 37·3 37·4
Previous use of antimalarial treatment 10 (2%) 13 (3%) 4 (1%) 3 (1%) 2 (1%) 4 (1%)
Positive malaria test 9 (2%) 15 (3%) 16 (5%) 9 (2%) 11 (3%) 14 (4%)
Health-facility level characteristics
Seen at dispensary 372 (88%) 367 (84%) 314 (88%) 333 (85%) 293 (88%) 273 (84%)
Seen at health facility with malaria microscopy 67 (16%) 121 (28%) 79 (22%) 119 (30%) 73 (22%) 105 (32%)
Seen at  health facility with at least one AL management wall chart 274 (65%) 284 (65%) 272 (76%) 274 (70%) 252 (76%) 252 (77%)
Seen at  health facility with all weight-speciﬁ c AL packs in stock 232 (55 %) 265 (60%) 50 (14%) 51 (13%) 30 (9%) 63 (19%)
Seen at health facility with  sulfadoxine-pyrimethamine  tablets in stock 413 (98%) 439 (100%) 354 (99%) 378 (97%) 332 (100%) 327 (100%)
Health-worker level characteristics
Exposure to AL management interventions
Seen by health worker trained on AL use 239 (57%) 261 (60%) 248 (69%) 256 (66%) 219 (66%) 232 (71%)
Seen by health worker with access to AL guidelines 366 (87%) 370 (84%) 293 (82%) 336 (86%) 308 (93%) 288 (88%)
Seen by health worker who received AL supervisory visit 95 (23%) 146 (33%) 126 (35%) 158 (40%) 147 (44%) 130 (40%)
Exposure to text-message intervention
Seen by health worker without exposure 422 (100%) 439 (100%) 354 (99%) 38 (10%)* 320 (96%) 16 (5%)†
Seen by health worker with only 1–5 months’ exposure 0 0 4 (1%)‡ 54 (14%)§ 0 26 (8%)¶
Seen by health worker with complete exposure 0 0 0 299 (77%) 12 (4%)|| 285 (87%)
Data are n (%) or mean (95% CI) unless otherwise stated. AL=artemether-lumefantrine. *Seen by four health workers transferred to intervention facilities after recruitment (29 children), one health worker on 
sick leave during the recruitment (six children), and one health worker who reported not receiving any messages (three children). †Seen by two health workers transferred to intervention facilities after 
recruitment (ten children), one health worker who was newly posted (four children), and one health worker who reported not receiving any messages (two children). ‡Seen by one health worker exposed for 
1 month who was transferred from intervention to control facility after recruitment. §Seen by three health workers who reported receiving text messages for 1, 1·5, and 5 months, respectively (33 children), 
one health worker who changed phone number after 3·5 months (17 children), and one health worker who requested to stop receiving text messages after 1 month because their facility was temporarily closed 
(four children). ¶Seen by four health workers who reported receiving text messages for 2 months and 5 months, respectively (18 children) and one health worker who lost thier phone after 1 month 
(eight children). ||Seen by one health worker who was transferred from intervention to control facility immediately after recruitment. 
Table 2: Characteristics of health facilities and children needing artemether-lumefantrine management, by study group and survey time 
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artemether-lumefantrine management were much the 
same between study groups and study times (table 2). 
However, more children were seen at baseline surveys 
than they were at follow-up surveys at facilities where all 
four weight-speciﬁ c artemether-lumefantrine packs were 
in stock on survey days (table 2). During the follow-up 
surveys at intervention facilities, 81% (584) of children 
were seen by health workers who received the complete 
6-month intervention and 2% (16) of children at control 
facilities were seen by health workers either partly or 
fully exposed to the intervention. 
In the intention-to-treat analysis, correct artemether-
lumefantrine management was improved immediately 
after intervention and at 6 months after intervention 
compared with baseline (table 3). We recorded 
improvements of similar eﬀ ect size when the perfor-
mance indicator was all four treatment tasks and at 
least ﬁ ve of six dispensing and counselling tasks; a 
21·4 percentage-point (95% CI 9·0–33·7, p=0·0007) 
improve ment immediately after the intervention and a 
23·7 percentage-point (11·6–35·7, p=0·0001) improve-
ment 6 months after the intervention. We also recorded 
improved performance when carers did all ten tasks, 
but the eﬀ ect sizes were smaller than they were when 
carers did the four treatment tasks and ﬁ ve of six 
dispensing and counselling tasks; 10·3 percentage-point 
(4·0–16·6, p=0·0013) immediately after the inter ven-
tion and 11·3 percentage-point (5·1–17·6, p=0·0004) 
6 months after the intervention ended.
Analysis of individual artemether-lumefantrine 
management components showed that the biggest 
improvements were achieved when the following four 
dispensing and counselling tasks were completed (all 
of which were rarely done before the intervention 
began): giving of the ﬁ rst dose at the health facility, 
counselling to give the second dose after 8 h, counselling 
to give the drug after a meal, and counselling on what 
to do in case of vomiting (table 3). We recorded little 
change in the completion of the remaining six tasks at 
6 months after intervention compared with baseline 
(table 3), but these tasks were done for most patients 
before the intervention began. All improvements 
recorded in the intention-to-treat analysis were also 
recorded in the per-protocol analysis, but eﬀ ect sizes 
were larger in that analysis—correct artemether-
lumefantrine management improved by 31·7 per-
centage-points (95% CI 15·6–47·8) during the 
immediate post-intervention survey and 28·6% 
percentage-points (12·7–44·6) during the late post-
intervention survey (webappendix p 1). 
Baseline Follow-up one Follow-up two Eﬀ ect size (diﬀ erence of diﬀ erences)
Control Intervention Control Intervention Control Intervention Immediately after end 
of intervention
6 months after end of 
intervention 
% change 
(95% CI)
p value % change 
(95% CI)
p value
Composite performance
Correctly managed 422/47 
(11·1%)
439/90 
(20·5%)
358/59 
(16·5%)
391/194 
(49·6%)
332/58 
(17·5%)
327/168 
(51·4%)
23·7%
(7·6 to 40·0)
0·0040 24·5%
(8·1 to 41·0)
0·0034
Individual components
1. Antimalarial treatment prescribed 422/347 
(82·2%)
439/358 
(81·6%)
358/302 
(84·4%)
391/336 
(85·9%)
332/271 
(81·6%)
327/273 
(83·5%)
2·1%
(–8·3 to 12·8)
0·6759 2·5%
(–9·1 to 14·1)
0·6676
2. AL treatment prescribed 347/303 
(87·3)
358/312 
(87·2)
302/239 
(79·1)
336/320 
(95·2)
271/234 
(86·4)
273/255 
(93·4)
16·2%
(1·1 to 31·5)
0·0361 7·1%
(–4·8 to 19·2)
0·2382
3. AL prescribed in recommended dose 303/291 
(96·0)
312/297 
(95·2)
239/225 
(94·1)
320/307 
(95·9)
234/218 
(93·2)
255/247 
(96·9)
2·6%
(–2·2 to 7·4)
0·2799 4·5%
(–1·2 to 10·3)
0·1196
4. AL dispensed to take home 303/302 
(99·7%)
312/309 
(99·0%)
239/239 
(100%)
320/319 
(99·7%)
234/234 
(100%)
255/255 
(100%)
0·4%
ND
ND 0·7%
ND
ND
5. First AL dose given at health facility 302/45 
(14·9%)
309/79 
(25·6%)
239/42 
(17·6%)
319/191 
(59·9%)
234/49 
(20·9%)
255/142 
(55·7%)
31·6%
(7·4 to 55·9)
0·0105 24·1%
(1·5 to 46·6)
0·0364
6. Explained how to take AL dose 302/287 
(95·0%)
309/282 
(91·3%)
239/233 
(97·5%)
319/316 
(99·1%)
234/219 
(93·6%)
255/250 
(98·0%)
5·3%
(–1·9 to 12·6)
0·1469 8·1%
(0·1 to 16·4)
0·0478
7. Advised to take second dose after 8 h 302/114 
(37·8%)
309/131 
(42·4%)
239/96 
(40·2%)
319/245 
(76·8%)
234/92 
(39·3%)
255/182 
(71·4%)
32·0%
(9·4 to 54·6)
0·0056 27·5%
(4·4 to 50·5)
0·0198
8. Advised to take AL after meal 302/103 
(34·1%)
309/107 
(34·6%)
239/109 
(45·6%)
319/164 
(51·4%)
234/108 
(46·2%)
255/168 
(65·9%)
5·3%
(–11·3 to 21·8)
0·5318 19·2%
(2·1 to 36·3)
0·0277
9. Advised what to do if vomiting occurs 302/22 
(7·3%)
309/17 
(5·5%)
239/20 
(8·4%)
319/85 
(26·7%)
234/12 
(5·1%)
255/71 
(27·8%)
20·1%
(7·5 to 32·6)
0·0017 24·5%
(12·6 to 36·4)
<0·0001
10. Advised to complete all doses 183/302 
(60·6%)
309/213 
(68·9%)
239/148 
(61·9%)
319/249 
(78·1%)
234/163 
(69·7%)
255/220 
(86·3%)
7·9%
(–9·4 to 25·0)
0·3740 8·3%
(–7·6 to 24·1)
0·3067
Data are N/n (%) unless otherwise stated. AL=artemether-lumefantrine; ND=not done (the model did not converge because outcome levels were very close to 100%).
Table 3: Correctness of artemether-lumefantrine management (intention-to-treat analysis)
See Online for webappendix
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Discussion
Our ﬁ ndings showed that simple one-way communication 
of text-message reminders sent to health workers’ 
personal mobile phones improved the quality of 
artemether-lumefantrine management. We recorded not 
only a short-term eﬀ ect of the intervention but also a 
long-term improvement 6 months afterwards.
We are not aware of any other studies that have assessed 
text-message reminders on health workers behaviour 
(panel 3). However, according to early results of a large 
systematic review of strategies to improve health worker 
performance in developing countries (213 eﬀ ect sizes 
from 172 studies with robust designs and none including 
text-message interventions), the median improvement 
was just 9% (IQR 3–23%).24 Of direct relevance for 
malaria case-management practices in Kenya, a study 
that measured case-management indicators similar to 
those in our study showed only slight (and not statistically 
signiﬁ cant) positive eﬀ ects of in-service training and 
passive distribution of job aids on health workers’ 
adherence to treatment guidelines.25 In the context of 
broader health applications of mobile phone technology 
in developing countries, our results complement the 
ﬁ ndings of trials in Kenya in which text-message 
communication between health workers and patients 
substantially improved patients’ adherence to anti-
retroviral treatment3,4 and HIV treatment outcomes.3
The intervention had a substantial eﬀ ect on the 
completion of four dispensing and counselling tasks that 
were rarely done before this study. First, giving of the 
ﬁ rst artemether-lumefantrine dose at a health facility 
improved by more than 20%. Completion of this task 
ensures prompt antimalarial treatment for children 
presenting to facilities but, as shown in Tanzania,9 is also 
associated with better adherence to the full course of 
artemisinin-based combination treatment. Second, 
improvements in counselling tasks related to the correct 
timing of the second artemether-lumefantrine dose 
(nearly 30%) and the giving of the drug after a meal 
(nearly 20%) are encouraging ﬁ ndings that are important 
to ensure successful treatment outcomes in view of the 
poor oral bioavailability of artemether-lumefantrine and 
varied absorption between doses.26–28 Third, febrile 
children with malaria often vomit after swallowing bitter 
antimalarial tablets. Therefore, the recorded 24·5% 
improvement in counselling on what to do if vomiting 
occurs oﬀ ers further encouragement. 
We do not fully understand why the intervention was 
successful.29 Our main assumption is that text-message 
reminders address health workers’ forgetfulness,30 
emphasise the clinical importance of doing tasks 
described in the messages, and increase the priority of 
doing the tasks because the text messages represent the 
voice of authority of the health workers’ employer (the 
Ministry of Health). However, whether the intervention 
in our setting also involves the communication of new or 
corrective information, or the enhancement of health 
workers’ feeling that someone is paying attention to their 
work (ie, the Hawthorne eﬀ ect31), is not clear. The 
intervention’s eﬀ ect could have had little to do with the 
malaria-related content of the messages but with 
increased motivation from the famous quotes and 
sayings. We are examining these questions with 
qualitative research methods, and hope to publish our 
ﬁ ndings by the end of 2011.
From a programmatic perspective, our ﬁ ndings have 
important implications for malaria case-management 
implementers in Kenya and elsewhere in Africa. Despite 
the encouraging results of our study against frequent 
reports of unsuccessful interventions to change clinical 
practices across the continent,15,16,24 we do not argue that 
text messaging should replace a traditional package of 
case-management interventions such as in-service 
training, supervision, and dissemination of guidelines 
and job aids. Our intervention provided large and 
sustained improvements in the quality of care given to 
children with malaria, but resulted in only about half the 
children being correctly managed. Therefore, we 
recommend that text-message reminders should be 
used to complement existing interventions—which 
themselves should be qualitatively improved—to target 
weak points in malaria case-management practices. In 
the Kenyan context, with 22 million people who subscribe 
to a mobile phone service32 and 86% of the population 
with access to mobile network coverage,33 and an even 
Panel 3: Research in context
Systematic review
On April 1, 2011, we searched a list of references from the Health Care Provider 
Performance (HCPP) review,23 a systematic review of studies of health worker 
performance in low-income and middle-income countries. The HCPP review included 
more than 105 000 studies that were identiﬁ ed by a search of 15 electronic databases 
(eg, Medline, CINHL, EPOC specialised register), the bibliographies of 510 previous 
reviews and other articles, document inventories, and websites of 29 organisations 
involved with health worker performance (eg, the US Centers for Disease Control and 
Prevention, World Bank, WHO), the bibliography of the International Network for 
Rational Use of Drugs, and the WHO Rational Use of Drugs database. Electronic databases 
were searched without language restrictions in May, 2006, and other sources were 
searched between 2006 and 2010. Adequate study designs were deﬁ ned as studies before 
and after interventions with a control group (with or without randomisation), studies 
done after intervention with a randomised control group, and interrupted time series. 
The HCPP review list (dated March 31, 2011) included 2430 references, 852 of which were 
studies with an adequate study design. To complement the search of electronic databases 
since 2006, on April 4, 2011 we also searched the Medline database with search terms 
“text-messaging” and screened 174 citations.
Interpretation
We know of no other study to examine the eﬀ ectiveness of mobile phone text-message 
reminders to improve health worker performance in a developing country. In our study, 
text-message reminders were associated with substantial improvements in health 
workers’ adherence to national guidelines for the management of outpatient paediatric 
malaria. In resource-limited settings, malaria control programmes should consider use of 
text-messaging to improve health workers’ case-management practices.
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higher likelihood of health facilities having network 
coverage, the pending large-scale implementation of a 
universal diagnostic policy for febrile patients34 oﬀ ers an 
opportunity for the government to implement behaviour 
change through text-messaging.34 As part of this activity, 
text-message reminders can be used to strengthen 
antimalarial treatment and dispensing and counselling 
practices, but also to reinforce testing of febrile patients, 
antimalarial treatment for only test-positive patients, 
and the need to assess children who test negative for 
malaria for other causes of fever. Across Africa, the 
network coverage will ultimately establish the feasibility 
of the intervention. Findings from remote districts in 
Tanzania suggest that large scale text-message 
applications in health are feasible.35
Because sending text-messages seemed like an 
insubstantial intervention, we hypothesised that frequent, 
repetitive reminders during a long period (6 months) 
would be needed for the intervention to be eﬀ ective. 
Moreover, because the study was intended to provide 
proof of concept, we thought that the testing of the 
intervention at a high dose would be best. Qualitative 
research with health workers exposed to the intervention 
should help reveal how burdensome the intervention was, 
and whether the intervention could be delivered for a 
period shorter than 6 months and expanded to other 
disease areas without losing eﬀ ectiveness.
The simplicity and low cost of text messaging means that 
widespread implementation of an intervention that uses 
this technology can be done quickly and successfully. For 
example, the cost of a text message in Kenya is about 
US$0·01,36 resulting in the cost of full exposure to our 
intervention of $2·6 per health worker, or $39 000 if scaled 
up to an estimated 15 000 health workers in all rural 
facilities nationwide.37 However, despite the low cost of 
sending a text message, additional costs and complexities 
exist in the establishment and maintenance of the 
distribution systems. We are undertaking a cost-
eﬀ ectiveness analysis under our trial conditions. In 
collaboration with the Kenyan Ministry of Health, we are 
also assessing the cost and operational requirements for 
the deployment and eﬀ ective maintenance of the text-
message distribution system on a national scale. These 
ﬁ ndings, together with better understanding of health 
workers’ views on the intervention’s modalities and 
underlying motivators that aﬀ ect their behaviour, will be 
crucial when considering national scale-up and replication 
of this intervention elsewhere.
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